drugset / Trial / NCT03538522
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
RandomizedParallel-groupQuadruple-blindOther
Summary
This study seeks to evaluate the efficacy and safety of NA-83 in subjects with mild cognitive impairment due to Alzheimer's Disease
Timeline
- Start
- 2018-09-15
- Primary completion
- 2019-09-30
- Completion
- 2019-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CYCLO(PROLYLGLYCYL) | Small molecule | 10 mg | Oral |
| Subject | CYCLO(PROLYLGLYCYL) | Small molecule | 20 mg | Oral |
| Subject | CYCLO(PROLYLGLYCYL) | Small molecule | 40 mg | Oral |